News Release Archive
- Leading experts slam current diabetes care in UK care homes – a Call to Action needed
- Roche announces urgent recall on certain Accu-Chek Aviva and Performa test strips
- Ramadan 2018 and fasting
- DVLA changes regulations
- Freestyle Libre available on the NHS!
- Medtronic recall specific lots of infusion sets with all models of Medtronic insulin pumps
- All Accu-Chek® Insight insulin pumps – risk of alarm failure
- WHO – long-acting analogues not an essential medicine
- Beef insulin discontinued
- Soft Drinks Warning!
- Driven to Despair
- 2017 – Getting back on track after Christmas
- Childhood Obesity Strategy failing our children
- Diabetes – What schools need to know
- DVLA – Good News!
- The National Diabetes Foot Care Audit (NDFA)
- Diabetes care criticised
- Motorists banned in error after faulty DVLA visual field test
- Too many children and young people with diabetes not getting the care they need
- National NHS Diabetes Prevention Programme
- InDependent Diabetes Trust: Young diabetics ‘get worse care’
- IDDT’s Position Statement – ‘pre-diabetes’
- MBE Is Bolt From The Blue For Charity Chair
- New insulin on the market – Insulin Degludec (Tresiba)
- Diabetes community urges more support for older people
- Warning to people with diabetes about dangerous herbal medicine
- In 1 week, 60 hospital patients with diabetes develop preventable complications – National Audit
- Passport for Diabetes in Care Settings
- Launch of Passport for Diabetes in Care Settings
- Type 2 Diabetes – Management & Medication
- Cost of insulin analogues
- Actos And The Risk Of Bladder Cancer – New Safety Warnings
- Actraphane – are patients really at the centre of care
- Marketing of insulin – a missed opportunity
- IDDT Launch Patient Hospital Passports
- IDDT Launch Public Awareness Campaign
- IDDT’s Position Statement on DTCA
- In Sickness and in Health
- IDDT Triumphs in Australia
WHO – long-acting analogues not an essential medicine
Health Action International today issued a press release commending the decision by the World Health Organization (WHO) to reject a proposal to include long-acting analogue insulin on the WHO Model List of Essential Medicines (EML).
A decision to include long-acting analogue insulin on the EML would have increased pressure on national governments to purchase these insulins, which are seven to nine times more expensive than human insulin, while providing limited added value to users. The result would have been fewer people being treated and more deaths.
To read the full press release, including comments from Health Action International’s Dr Margaret Ewen, co-lead of the Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) Study, please click here.
IDDT
Join Us
Please show your support by joining IDDT or renewing your membership now.
We rely on voluntary donations and appreciate any help you can give.
Find out the great benefits of becoming a member.
IDDT Helpline
IDDT has a CONFIDENTIAL Helpline,
find out more.
Donate
Want to donate?
You don’t have to be a member to donate, you can use the buttons below to donate from the Just Giving or Charity Checkout websites. Thank you.
IDDT Lottery
All the money that we raise through the IDDT Lottery goes directly to help people with diabetes and their families.
Find out more.
NICE Guidelines
NICE is an independent organisation responsible for providing national guidance on promoting good health.
Contact Info
InDependent Diabetes Trust
PO Box 294
Northampton
NN1 4XS
UK
01604 622837
01604 622838
enquiries@iddtinternational.org
An umbrella organisation
Looking for our Publications?
Looking for our Publications?
All IDDT publications are now accessible via the main Publications menu at the top of the page
IDDT Shop
Recycle to raise funds for IDDT
Recycle to raise funds
for IDDT
Empty inkjet cartridges click here
Give to IDDT with eBay click here
External Links
